Contents

Issue 155 • June 2025

In association with

Cover Story

Are regulators keeping pace with AI adoption in clinical trials?

Analyst Comment

ATS 2025: Anti–IL-5 therapy cuts exacerbations in COPD/asthma patients

Feature

Newborn screening strategy needs modernising 

In Depth

Are regulators keeping pace with AI adoption in clinical trials?

Power of collaboration more pertinent than ever says pharma experts

Newborn screening strategy needs modernising as HHS disbands advisory committee

Pharma’s AI prospects get nudged into the future with EU’s AI act

ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients

ATS 2025: Real-world data supports Trikafta as gold standard in long-term CF care

Briefing

News in Numbers

Latest News

Latest Deals

05/23/2025 08:35:56
  • Home | Are regulators keeping pace with AI adoption in clinical trials?
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Cartherics Company Insight
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Datwyler Company Insight
  • Datwyler
  • Nipro
  • In Depth
  • Are regulators keeping pace with AI adoption in clinical trials?
  • Power of collaboration more pertinent than ever says pharma experts
  • Newborn screening strategy needs modernising as HHS disbands advisory committee
  • Pharma’s AI prospects get nudged into the future with EU’s AI act
  • ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients
  • ATS 2025: Real-world data supports Trikafta as gold standard in long-term CF care
  • B Medical Systems Company Insight
  • Endress+Hauser
  • SCHOTT Pharma Company Insight
  • Listings
  • Events
  • Excellence Awards
  • Buyer's Guides
  • Next issue
05/23/2025 00:00:00